Select a Region
North America

Your hub for company news and information

Recent Press Releases

EVERSANA
Posted on 6月 5, 20236/5/23

EVERSANA INTOUCH Wins Five Clio Awards

EVERSANA
Posted on 6月 1, 20236/1/23

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

Posted on 5月 25, 20235/25/23

Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

EVERSANA
Posted on 5月 22, 20235/22/23

Yaral Pharma Partners with EVERSANA to Support the Commercialization of its Expanded Generics Portfolio

Posted on 5月 16, 20235/16/23

Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States

EVERSANA
Posted on 5月 16, 20235/16/23

Two EVERSANA Leaders Named to Prestigious PM360 Elite 100 List

Posted on 5月 9, 20235/9/23

Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources

Posted on 3月 30, 20233/30/23

EVERSANA Named 2023 Artificial Intelligence Excellence Award Winner for Synthetic Content Program

Posted on 3月 23, 20233/23/23

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis   

Posted on 3月 21, 20233/21/23

APACMed Names EVERSANA® Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region